Dr. M. VANHOUDT

Active

Private limited companyfounded 1992active for 34 yearsKauwendaal(MeSK) 10, 2800 Mechelen, BelgiumKBO/BCE: BE 0446.944.425

Summary

Dr. M. VANHOUDT has been active since 1992 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.2m and a net result of €430,725. Equity is growing by about 14% per year across the filed financial years. Its solvency ranks better than 68% of 20,604 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

Dr. M. VANHOUDTActiveChecked score 96/100

Risk analysis Report Compare

Activity

General medical practice

NACE 86210

1 site

Size

€2.8mtotal assets 2025

Staff: 3 FTE
Equity: €2.2m
Profit: €430,725

Turnover not published (micro format)

Financial health

96 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Structure

Marc VanhoudtDirector
Magdalena Van LoonDirector

2025 accounts on time2 of 10 deeds summarised

Why 96lowers riskSector: Human health activities (NACE 86)Size: total assets €2.8mFigures for financial year 2025 (filed 30-04-2026)Equity €2.2m (78.5% of total assets)Show the evidence

Checked score

Score 2025

96 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 68% of its sector peers (NACE 86, small)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 100=

equity 78.5% of total assets

Liquidity 57-4

short-term debt 21.5% · cash 11.1%

Profitability 88+2

return on assets 15.6%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,074 companies, NACE 86, small)

Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025highest value 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026

Credit of up to €200,000 on 30-day terms is acceptable

Liquidity ample (current ratio 4.3, compared with 3.68 in 2024, above the usual 1.5; short-term debt: 21.5% and cash: 11.1% of total assets), and 21.5% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small): better than 77% on solvency, 38% on liquidity, 75% on profitability and 83% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskneutral

Sector: Human health activities (NACE 86)

KBO

Size: total assets €2.8m

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Figures for financial year 2025 (filed 30-04-2026)

NBB · annual accounts

Equity €2.2m (78.5% of total assets)

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 30-04-2026, 0 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

on the day

2024

21 days late

2023

20 days late

2022

6 days early

2021

2 days late

2020

3 days late

2019

13 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 4 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 2 May (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

30-09-2026 year end25-10-2026 today30-04-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

30-04-2026 Annual accounts filedfinancial year 2025 · micro…
30-09-2025 Highest result from 2019 to 2025net €430,725 ▲32.2%
30-09-2025 Equity above €2mequity €2.2m ▲20.6%

Key points

Positive: Among the best 5% on net resultsector median €60,202 · 20,591 companies €430,725 View
Positive: 7 profitable years in a rowprofit 2025: €430,725 7 years View
Positive: Result rose in 2025from €325,936 to €430,725 ▲ 32.2% View

By topic

Financials

Financial year: 2025
Total assets: €2.8m
Profit: €430,725
Solvency: 78.5%

Total assets▲ 15.7%

Net result

20192025

Go to Financials

Board & ownership

Board: 2 members

Marc VanhoudtDirector
Magdalena Van LoonDirector

Go to Board & ownership

Timeline

Events: 38
Since: 1994
Next accounts: by 30-04-2027

21-05-2025Annual accounts filed
01-07-2024Reappointment: Marc Vanhoudt (director)
20-05-2024Annual accounts filed

Go to Timeline

Company details

Sites: 1

Legal form: Private limited company
Activity: General medical practiceNACE 86210
Founded: 17-03-1992
Year ends: 30-09
Peppol: Not found in the Peppol directory

Go to Company details

Key facts about Dr. M. VANHOUDT

What is the company number of Dr. M. VANHOUDT?: 0446.944.425. In Belgium the VAT number is the company number with BE in front: BE 0446.944.425.
Where is Dr. M. VANHOUDT based?: The registered office is at Kauwendaal(MeSK) 10, 2800 Mechelen.Company details
What does Dr. M. VANHOUDT do?: According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. M. VANHOUDT?: Private limited company (BV).
When was Dr. M. VANHOUDT founded?: On 17-03-1992.
Is Dr. M. VANHOUDT still active?: Yes, Dr. M. VANHOUDT is an active enterprise in the KBO register.
How many employees does Dr. M. VANHOUDT have?: On average 3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Dr. M. VANHOUDT?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is Dr. M. VANHOUDT profitable?: In financial year 2025, Dr. M. VANHOUDT made a profit of €430,725.
Where can I find the annual accounts of Dr. M. VANHOUDT?: Dr. M. VANHOUDT filed 33 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. M. VANHOUDT due?: By 30-04-2027, for financial year 2026.Timeline